Skip to content

Assessment of lung ventilation and perfusion distribution in patients with AHRF in the Icu

Assessment of lung ventilation and perfusion distribution in patients with AHRF in the Icu

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118446
Enrollment
Unknown
Registered
2026-02-05
Start date
2025-01-01
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute hypoxemic respiratory failure,AHRF

Interventions

Observational group:None

Sponsors

The First Affiliated Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients who have undergone or are expected to require invasive mechanical ventilation within 6h; 2. Age >=18 years; 3. Arterial blood gas analysis within 6h of admission to the ICU to meet the arterial partial pressure of oxygen (PaO2):inspired oxygen concentration (FiO2) ratio <300; 4. Indwelling arterial blood pressure monitoring and central venous catheter (internal jugular vein or subclavian vein catheter);

Exclusion criteria

Exclusion criteria: 1. Age <18 years old; 2. Pregnant and lactating women; 3. Expected to stay in the ICU for <=24h; 4. Thoracic deformities and any contraindications to the use of EIT (automated implantable cardioverter-defibrillator, thoracic wounds limiting electrode band placement, implantable pumps, etc.); 5. Patients with iodine contrast allergy; 6. Patients with contraindications to indwelling arterial blood pressure monitoring and central venous catheterization; patients with contraindications to placement of right median elbow vein indwelling needle; 7. Patients with severe thyroid disorders (hyperthyroidism); 8. Patients who had undergone cardiopulmonary resuscitation before the study, those with advanced malignant tumors, terminal stages of other diseases, or those who were considered by the clinician to be dying within 48h.

Design outcomes

Primary

MeasureTime frame
Three tools were used to evaluate the regional proportion thresholds of ventilation and blood flow matching (Shunt, Deadspace, GBR > 1, GBR < 1, NSND) for each type of AHRF;

Secondary

MeasureTime frame
Patient ICU length of stay;Duration of mechanical ventilation;ICU Survival or not;Survival of hospitalization;28 days of survival or not;Mechanical ventilation parameters before and after patient treatment;APACHE II and Sofa Ratings;Hemoglobin;D-dimer;Ultrasensitive C-reactive protein;Calcitonin;Arterial blood gas analysis;

Countries

China

Contacts

Public ContactZheng Xia

The First Affiliated Hospital, Zhejiang University School of Medicine

zxicu@zju.edu.cn+86 139 5817 4689

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026